The integration of microarray information in the drug development process.
In the past year, microarray technologies have moved beyond the proof-of-principle stage. Microarrays are now being used for genome-wide expression monitoring, large-scale polymorphism screening and mapping, and for the evaluation of drug candidates.
Braxton
S
S
Synteni Inc. 6519 Dumbarton Circle Fremont CA 94555 USA. Braxton@synteni.com.
Bedilion
T
T
D000818:Animals; D001709:Biotechnology / Q000379:methods*; D002460:Cell Line; D002874:Chromosome Mapping; D003001:Cloning, Molecular; D015195:Drug Design; D004358:Drug Therapy; D005821:Genetic Techniques; D006801:Humans